Loading...

Arthur L Swislocki, MD

Title(s)Professor, Endocrinology, Diabetes, And Metabolism
SchoolUniversity of California, Davis
Phone916-734-3730
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hernandez L, Leutwyler H, Cataldo J, Kanaya A, Swislocki A, Chesla C. The Lived Experience of Older Adults With Type 2 Diabetes Mellitus and Diabetes-Related Distress. J Gerontol Nurs. 2020 Mar 01; 46(3):37-44. PMID: 32083700.
      View in: PubMed
    2. Hernandez L, Leutwyler H, Cataldo J, Kanaya A, Swislocki A, Chesla C. Symptom Experience of Older Adults With Type 2 Diabetes and Diabetes-Related Distress. Nurs Res. 2019 Sep/Oct; 68(5):374-382. PMID: 31465305.
      View in: PubMed
    3. Sood A, Swislocki A. Nonglycemic Effects of GLP-1 Agonists: From a Starling to Lizards to People. Metab Syndr Relat Disord. 2019 Jul/Aug; 17(6):303-313. PMID: 31145029.
      View in: PubMed
    4. Villegas K, Meier JL, Long M, Lopez J, Swislocki A. The Effect of Proton Pump Inhibitors on Glycemic Control in Patients with Type 2 Diabetes. Metab Syndr Relat Disord. 2019 05; 17(4):192-196. PMID: 30730235.
      View in: PubMed
    5. Morotti K, Lopez J, Vaupel V, Swislocki A, Siegel D. Adherence to and Persistence With Statin Therapy in a Veteran Population. Ann Pharmacother. 2019 01; 53(1):43-49. PMID: 30084646.
      View in: PubMed
    6. Chang DJ, Lippman SS, Semrad AM, Volpp B, Swislocki ALM. Prevalence of Suspicious Ultrasound Features in Hot Thyroid Nodules. Fed Pract. 2018 May; 35(Suppl 4):S46-S48. PMID: 30766400.
      View in: PubMed
    7. Rodnick KJ, Holman RW, Ropski PS, Huang M, Swislocki ALM. A Perspective on Reagent Diversity and Non-covalent Binding of Reactive Carbonyl Species (RCS) and Effector Reagents in Non-enzymatic Glycation (NEG): Mechanistic Considerations and Implications for Future Research. Front Chem. 2017; 5:39. PMID: 28713809.
      View in: PubMed
    8. Swislocki AL, Jialal I. Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study. Metab Syndr Relat Disord. 2016 10; 14(8):375-377. PMID: 27552667.
      View in: PubMed
    9. Swislocki AL, Jialal I. Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest? Metab Syndr Relat Disord. 2016 Feb; 14(1):3-6. PMID: 26677930.
      View in: PubMed
    10. Aterrado S, Ono G, Kanehira-Mar S, Meier J, Swislocki A. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients. Ann Pharmacother. 2015 Sep; 49(9):969-77. PMID: 26104054.
      View in: PubMed
    11. Swislocki AL, Jialal I. The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors. Metab Syndr Relat Disord. 2015 Sep; 13(7):287-91. PMID: 25893855.
      View in: PubMed
    12. LaFleur J, Steenhoek CL, Horne J, Meier J, Nebeker JR, Mambourg S, Swislocki A, Carmichael J. Comparing fracture absolute risk assessment (FARA) tools: an osteoporosis clinical informatics tool to improve identification and care of men at high risk of first fracture. Ann Pharmacother. 2015 May; 49(5):506-14. PMID: 25712443.
      View in: PubMed
    13. Leary J, Swislocki A. Hypothalamic-Pituitary-Adrenal Suppression and Iatrogenic Cushing's Syndrome as a Complication of Epidural Steroid Injections. Case Rep Endocrinol. 2013; 2013:617042. PMID: 23991341.
      View in: PubMed
    14. Swislocki A. HbA1c and metabolic syndrome. Metab Syndr Relat Disord. 2012 Dec; 10(6):391-3. PMID: 23025691.
      View in: PubMed
    15. Swislocki AL, Siegel D, Jialal I. Pharmacotherapy for the metabolic syndrome. Curr Vasc Pharmacol. 2012 Mar; 10(2):187-205. PMID: 22022773.
      View in: PubMed
    16. Chock B, Lin TC, Li CS, Swislocki A. Plasma testosterone is associated with Framingham risk score. Aging Male. 2012 Sep; 15(3):134-9. PMID: 22364636.
      View in: PubMed
    17. Kelley DS, Adkins Y, Woodhouse LR, Swislocki A, Mackey BE, Siegel D. Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men. Metab Syndr Relat Disord. 2012 Feb; 10(1):32-8. PMID: 21999398.
      View in: PubMed
    18. Swislocki AL, Meier JL, Najera SM, Noth RH. Long-term maintenance of glucose control in veterans with type 2 diabetes mellitus using oral agents. Metab Syndr Relat Disord. 2011 Dec; 9(6):469-73. PMID: 21864034.
      View in: PubMed
    19. Garcia EA, Lopez JR, Meier JL, Swislocki AL, Siegel D. Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):487-91. PMID: 21762361.
      View in: PubMed
    20. Siegel D, Swislocki AL. The ACCORD Study: the devil is in the details. Metab Syndr Relat Disord. 2011 Apr; 9(2):81-4. PMID: 21166575.
      View in: PubMed
    21. Swislocki A, Green JA, Heinrich G, Barnett CA, Meadows ID, Harmon EB, Rank MF, Noth RH. Prevalence of osteoporosis in men in a VA rehabilitation center. Am J Manag Care. 2010 Jun; 16(6):427-33. PMID: 20560686.
      View in: PubMed
    22. Siegel D, Swislocki AL. Hypertensive treatment in patients with metabolic syndrome. Metab Syndr Relat Disord. 2010 Apr; 8(2):95-104. PMID: 20156078.
      View in: PubMed
    23. Libby A, Meier J, Lopez J, Swislocki AL, Siegel D. The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin. Metab Syndr Relat Disord. 2010 Feb; 8(1):79-84. PMID: 19943800.
      View in: PubMed
    24. Keane J, Meier JL, Noth RH, Swislocki AL. Computer-based screening of veterans for metabolic syndrome. Metab Syndr Relat Disord. 2009 Dec; 7(6):557-61. PMID: 19558266.
      View in: PubMed
    25. Swislocki A, Orth M, Bales M, Weisshaupt J, West C, Edrington J, Cooper B, Saputo L, Islas M, Miaskowski C. A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Symptom Manage. 2010 Jan; 39(1):88-99. PMID: 19896325.
      View in: PubMed
    26. Swislocki A, Noth RH, Volpp B, Meier J, Siegel D. Computer confirmation of improved blood pressure control in diabetic patients. Prev Cardiol. 2009; 12(3):149-54. PMID: 19523058.
      View in: PubMed
    27. Swislocki AL, Fakiri Z. Smokeless nicotine exposure has no lasting effect on fasting or postglucose circulation leptin in young rats. Metab Syndr Relat Disord. 2008 Dec; 6(4):257-62. PMID: 19067528.
      View in: PubMed
    28. Nakai Y, Noth R, Wexler J, Volpp B, Tsodikov A, Swislocki A. Computer-based screening of chest X-rays for vertebral compression fractures as an osteoporosis index in men. Bone. 2008 Jun; 42(6):1214-8. PMID: 18395504.
      View in: PubMed
    29. Siegel D, Meier J, Maas C, Lopez J, Swislocki AL. The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients. Am J Hypertens. 2008 Apr; 21(4):438-42. PMID: 18246056.
      View in: PubMed
    30. Swislocki A, Lardinois CK, Starich GH. Acarbose attenuates Basal and postprandial insulin concentrations but fails to lower blood pressure in the spontaneously hypertensive rat. Metab Syndr Relat Disord. 2007 Dec; 5(4):297-304. PMID: 18370799.
      View in: PubMed
    31. Siegel D, Swislocki AL. Effects of antihypertensives on glucose metabolism. Metab Syndr Relat Disord. 2007 Sep; 5(3):211-9. PMID: 18370775.
      View in: PubMed
    32. Swislocki AL, Wexler JA. The stumble-from pipe cleaner to bone builder. Endocr Pract. 2007 Mar-Apr; 13(2):194-7. PMID: 17490936.
      View in: PubMed
    33. Barengolts EI, Burke BV, Duckworth WC, Kaminsky R, Miller DR, Swislocki AL. Adoption of a new technology in a Veterans Affairs national formulary system with local implementation: the insulin glargine example. Manag Care Interface. 2007 Mar; 20(3):37-44, 57. PMID: 17458480.
      View in: PubMed
    34. Swislocki A, Noth RH, Volpp B, Meier J, Siegel D. Blood pressure control in a diabetic population assessed by computer review. J Hum Hypertens. 2006 Jul; 20(7):540-2. PMID: 16543913.
      View in: PubMed
    35. Swislocki A, Noth R, Hallstone A, Kyger E, Triadafilopoulos G. Secretin-stimulated amylase release into blood is impaired in type 1 diabetes mellitus. Horm Metab Res. 2005 May; 37(5):326-30. PMID: 15971157.
      View in: PubMed
    36. Swislocki AL. Smokeless nicotine administration does not result in hypertension or a deterioration in glucose tolerance or insulin sensitivity in juvenile rats. Metabolism. 2003 Jan; 52(1):67-72. PMID: 12524664.
      View in: PubMed
    37. Swislocki A, Burgie ES, Rodnick KJ. Effects of ovariectomy on indices of insulin resistance, hypertension, and cardiac energy metabolism in middle-aged spontaneously hypertensive rats (SHR). Horm Metab Res. 2002 Sep; 34(9):516-22. PMID: 12384829.
      View in: PubMed
    38. Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. Am J Manag Care. 2002 Jun; 8(6):557-65. PMID: 12068962.
      View in: PubMed
    39. LaPier TL, Swislocki AL, Clark RJ, Rodnick KJ. Voluntary running improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats. Am J Hypertens. 2001 Jul; 14(7 Pt 1):708-15. PMID: 11465658.
      View in: PubMed
    40. Swislocki AL, Siegel D. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes. Am J Manag Care. 2001 Mar; 7(3):283-95. PMID: 11258145.
      View in: PubMed
    41. Grinsell JW, Lardinois CK, Swislocki A, Gonzalez R, Sare JS, Michaels JR, Starich GH. Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat. Am J Hypertens. 2000 Apr; 13(4 Pt 1):370-5. PMID: 10821338.
      View in: PubMed
    42. Swislocki AL, LaPier TL, Khuu DT, Fann KY, Tait M, Rodnick KJ. Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats. Am J Hypertens. 1999 Jun; 12(6):581-9. PMID: 10371367.
      View in: PubMed
    43. Siegel D, Swislocki AL. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1999 Feb 03; 281(5):417-9. PMID: 9952198.
      View in: PubMed
    44. Haq IU, Wallis EJ, Yeo WW, Jackson PR, Ramsay LE. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1999 Feb 03; 281(5):414; author reply 417-9. PMID: 9952191.
      View in: PubMed
    45. Swislocki AL, Khuu Q, Liao E, Wu E, Beza F, Lopez J, Kwan G, Noth RH. Safety and efficacy of metformin in a restricted formulary. Am J Manag Care. 1999 Jan; 5(1):62-8. PMID: 10345968.
      View in: PubMed
    46. Swislocki AL, Noth R. Case report. Pseudohepatotoxicity of metformin. Diabetes Care. 1998 Apr; 21(4):677-8. PMID: 9571371.
      View in: PubMed
    47. Swislocki AL, Barnett CA, Darnell P, Noth RH. Hyperthyroidism: an underappreciated cause of diffuse bone disease. Clin Nucl Med. 1998 Apr; 23(4):241-3. PMID: 9554201.
      View in: PubMed
    48. Swislocki AL, Goodman MN, Khuu DT, Fann KY. Insulin resistance and hypertension: in vivo and in vitro insulin action in skeletal muscle in spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens. 1997 Oct; 10(10 Pt 1):1159-64. PMID: 9370388.
      View in: PubMed
    49. Swislocki AL, Lin K, Cogburn D, Fann KY, Khuu DT, Noth RH. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study. Am J Manag Care. 1997 Oct; 3(10):1537-45. PMID: 10178460.
      View in: PubMed
    50. Swislocki AL, Tsuzuki A, Tait M, Khuu D, Fann K. Smokeless nicotine administration is associated with hypertension but not with a deterioration in glucose tolerance in rats. Metabolism. 1997 Sep; 46(9):1008-12. PMID: 9284888.
      View in: PubMed
    51. Swislocki A, Eason T, Kaysen GA. Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats. Am J Hypertens. 1995 Oct; 8(10 Pt 1):1009-14. PMID: 8845069.
      View in: PubMed
    52. Swislocki AL. Impaired insulin clearance in essential hypertension. J Hum Hypertens. 1994 Mar; 8(3):185-90. PMID: 7911838.
      View in: PubMed
    53. Swislocki A, Tsuzuki A. Insulin resistance and hypertension: glucose intolerance, hyperinsulinemia, and elevated free fatty acids in the lean spontaneously hypertensive rat. Am J Med Sci. 1993 Nov; 306(5):282-6. PMID: 8238081.
      View in: PubMed
    54. Swislocki A, Noth R, Kaplan R, Dowdell L, Lamothe J, Claire D, Smith C, Fishman I, Onufer C. Microalbuminuria in a normotensive insulin-treated diabetic population. Horm Metab Res. 1993 Oct; 25(10):532-5. PMID: 8262462.
      View in: PubMed
    55. Caticha O, Odell WD, Wilson DE, Dowdell LA, Noth RH, Swislocki AL, Lamothe JJ, Barrow R. Estradiol stimulates cortisol production by adrenal cells in estrogen-dependent primary adrenocortical nodular dysplasia. J Clin Endocrinol Metab. 1993 Aug; 77(2):494-7. PMID: 8345057.
      View in: PubMed
    56. Swislocki AL, Vestal RE, Reaven GM, Hoffman BB. Acute metabolic effects of clonidine and adenosine in man. Horm Metab Res. 1993 Feb; 25(2):90-5. PMID: 8458615.
      View in: PubMed
    57. Swislocki A, Cram D, Noth R, Dowdell L, Lamothe J, Ogi G. Insulin syringe disposal patterns at a VA hospital. Diabetes Care. 1991 Oct; 14(10):930-2. PMID: 1773698.
      View in: PubMed
    58. Sheu WH, Swislocki AL, Hoffman B, Chen YD, Reaven GM. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens. 1991 Mar; 4(3 Pt 1):199-205. PMID: 2043298.
      View in: PubMed
    59. Chen YD, Sheu WH, Swislocki AL, Reaven GM. High density lipoprotein turnover in patients with hypertension. Hypertension. 1991 Mar; 17(3):386-93. PMID: 1900259.
      View in: PubMed
    60. Izzo JL, Swislocki AL. Workshop III--Insulin resistance: is it truly the link? Am J Med. 1991 Feb 21; 90(2A):26S-31S. PMID: 1994712.
      View in: PubMed
    61. Swislocki AL, Camargo CA, Hoffman AR. McCune-Albright syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadism. West J Med. 1990 Dec; 153(6):653-6. PMID: 2293479.
      View in: PubMed
    62. Sheu WH, Swislocki AL, Hoffman BB, Reaven GM, Chen YD. Effect of prazosin treatment on HDL kinetics in patients with hypertension. Am J Hypertens. 1990 Oct; 3(10):761-8. PMID: 2121164.
      View in: PubMed
    63. Swislocki A, Dowdell L, Noth R. California living II: not-the-big-one had no effect on blood pressure. JAMA. 1990 Sep 19; 264(11):1411. PMID: 2391737.
      View in: PubMed
    64. Swislocki A. Insulin resistance and hypertension. Am J Med Sci. 1990 Aug; 300(2):104-15. PMID: 2206054.
      View in: PubMed
    65. Swislocki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1989 Jun; 2(6 Pt 1):419-23. PMID: 2667570.
      View in: PubMed
    66. Coulston AM, Hollenbeck CB, Swislocki AL, Reaven GM. Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care. 1989 Feb; 12(2):94-101. PMID: 2539286.
      View in: PubMed
    67. Swislocki AL, Hoffman BB, Sheu WH, Chen YD, Reaven GM. Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension. Am J Med. 1989 Jan 23; 86(1B):14-8. PMID: 2643861.
      View in: PubMed
    68. Eichler HG, Ford GA, Blaschke TF, Swislocki A, Hoffman BB. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy. J Clin Invest. 1989 Jan; 83(1):108-12. PMID: 2562959.
      View in: PubMed
    69. Chen YD, Swislocki AL, Jeng CY, Juang JH, Reaven GM. Effect of time on measurement of hepatic glucose production. J Clin Endocrinol Metab. 1988 Nov; 67(5):1084-8. PMID: 3182959.
      View in: PubMed
    70. Reaven GM, Swislocki AL, Jeng CY, Hollenbeck CB, Schwartz K, Chen YD. Effect of enprostil on plasma glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Horm Metab Res. 1988 Oct; 20(10):633-6. PMID: 3146538.
      View in: PubMed
    71. Rodnick KJ, Haskell WL, Swislocki AL, Foley JE, Reaven GM. Improved insulin action in muscle, liver, and adipose tissue in physically trained human subjects. Am J Physiol. 1987 Nov; 253(5 Pt 1):E489-95. PMID: 3318492.
      View in: PubMed
    72. Swislocki AL, Chen YD, Golay A, Chang MO, Reaven GM. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia. 1987 Aug; 30(8):622-6. PMID: 3308603.
      View in: PubMed
    73. Coulston AM, Hollenbeck CB, Swislocki AL, Reaven GM. Effect of source of dietary carbohydrate on plasma glucose and insulin responses to mixed meals in subjects with NIDDM. Diabetes Care. 1987 Jul-Aug; 10(4):395-400. PMID: 3304893.
      View in: PubMed
    74. Golay A, Swislocki AL, Chen YD, Reaven GM. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism. 1987 Jul; 36(7):692-6. PMID: 3298937.
      View in: PubMed
    75. Swislocki AL, Donner CC, Fraze E, Chen YD, Reaven GM. Can insulin resistance exist as a primary defect in noninsulin-dependent diabetes mellitus? J Clin Endocrinol Metab. 1987 Apr; 64(4):778-82. PMID: 3546354.
      View in: PubMed
    76. Coulston AM, Hollenbeck CB, Swislocki AL, Chen YD, Reaven GM. Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med. 1987 Feb; 82(2):213-20. PMID: 3544839.
      View in: PubMed
    77. Chen YD, Golay A, Swislocki AL, Reaven GM. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1987 Jan; 64(1):17-21. PMID: 3782431.
      View in: PubMed
    78. Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1987 Jan; 64(1):106-10. PMID: 3536980.
      View in: PubMed
    79. Golay A, Swislocki AL, Chen YD, Jaspan JB, Reaven GM. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab. 1986 Aug; 63(2):481-4. PMID: 3522620.
      View in: PubMed
    80. Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1985 Nov; 61(5):807-11. PMID: 3900120.
      View in: PubMed